Discover top growth stocks using the IBD Screen Of The Day. The RS Rating assesses a stock's price performance over 52 weeks compared to others. Focus on RS Ratings above 80 for big gains. Analyze Mirum Pharmaceuticals for potential breakout.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing
